{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:49:04Z","timestamp":1790419744739,"version":"4.1.0"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The genetics of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a complex area of investigation because of the low frequency of AAVs, the rarity of familial cases and the complexity of disease phenotypes. However, recent studies have been able to gather significant numbers of patients, and multicentre collaborative efforts have allowed the performance of two genome-wide association studies (GWASs). Genetic association studies based on candidate gene approaches and the two GWASs have greatly contributed to our current understanding of the genetic basis of AAV. The central role of autoimmunity has been confirmed by the significant association with HLA polymorphisms; interestingly, the three main AAV subtypes are associated with distinct HLA variants, i.e. granulomatosis with polyangiitis (Wegener's GPA) with HLA-DP1, microscopic polyangiitis with HLA-DQ and eosinophilic GPA (Churg-Strauss) with HLA-DRB4. GWASs also revealed that polymorphic variants of genes encoding proteinase 3 (PR3), the predominant antigenic target of ANCA in GPA, and its main inhibitor, alpha-1 antitrypsin, are highly associated with GPA and, even more significantly, with PR3-ANCA positivity (regardless of the clinical diagnosis); this emphasizes the central pathogenic role of PR3 and humoral autoimmunity in PR3-ANCA positive vasculitis. Finally, candidate gene approach studies have shown associations with other variants involved in autoimmunity, such as those belonging to the CTLA-4 and PTPN22 genes, although these findings warrant replication in larger studies. Additional studies are underway to better characterize disease associations within the AAV spectrum, which could provide new pathogenetic clues and possibly new treatment targets.<\/jats:p>","DOI":"10.1093\/ndt\/gfu386","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T05:57:03Z","timestamp":1418968623000},"page":"i37-i45","source":"Crossref","is-referenced-by-count":10,"title":["Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis"],"prefix":"10.1093","volume":"30","author":[{"given":"Federico","family":"Alberici","sequence":"first","affiliation":[{"name":"University of Cambridge School of Clinical Medicine 1 Department of Medicine , , Cambridge ,","place":["UK"]},{"name":"Addenbrooke's Hospital 2 Vasculitis and Lupus Service , , Cambridge ,","place":["UK"]},{"name":"University Hospital of Parma 3 Nephrology Unit , , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Martorana","sequence":"additional","affiliation":[{"name":"University Hospital of Parma 4 Unit of Medical Genetics , , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[{"name":"University Hospital of Parma 3 Nephrology Unit , , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,18]]},"reference":[{"key":"2025102312473949900_GFU386C1","first-page":"187","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume-title":"Arthritis Rheum","author":"Jennette","year":"1994"},{"key":"2025102312473949900_GFU386C2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"2025102312473949900_GFU386C3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","article-title":"Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis","volume":"72","author":"Mahr","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025102312473949900_GFU386C4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2025102312473949900_GFU386C5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"2025102312473949900_GFU386C6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"2025102312473949900_GFU386C7","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/art.38036","article-title":"Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis","volume":"65","author":"Xie","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gene.2009.44","article-title":"Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients","volume":"10","author":"Wieczorek","year":"2009","journal-title":"Genes Immun"},{"key":"2025102312473949900_GFU386C9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2350-10-121","article-title":"Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis","volume":"10","author":"Carr","year":"2009","journal-title":"BMC Med Genet"},{"key":"2025102312473949900_GFU386C10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kep420","article-title":"Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener's granulomatosis and Churg-Strauss syndrome","volume":"49","author":"Wieczorek","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2025102312473949900_GFU386C11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.gene.6364262","article-title":"Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese","volume":"7","author":"Tsuchiya","year":"2006","journal-title":"Genes Immun"},{"key":"2025102312473949900_GFU386C12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.23209","article-title":"Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al","volume":"58","author":"Wieczorek","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C13","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.22834","article-title":"HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome","volume":"56","author":"Vaglio","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C14","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/art.23496","article-title":"Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis","volume":"58","author":"Wieczorek","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2350-10-22","article-title":"Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis","volume":"10","author":"Carr","year":"2009","journal-title":"BMC Med Genet"},{"key":"2025102312473949900_GFU386C16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00109-009-0580-y","article-title":"A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis","volume":"88","author":"Wieczorek","year":"2010","journal-title":"J Mol Med (Berl)"},{"key":"2025102312473949900_GFU386C17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/art.21653","article-title":"Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis","volume":"54","author":"Miyashita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/gene.2008.5","article-title":"Association of LILRA2 (ILT1, LIR7) splice site polymorphism with systemic lupus erythematosus and microscopic polyangiitis","volume":"9","author":"Mamegano","year":"2008","journal-title":"Genes Immun"},{"key":"2025102312473949900_GFU386C19","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1002\/art.21487","article-title":"The PTPN22 620W allele is a risk factor for Wegener's granulomatosis","volume":"52","author":"Jagiello","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/rheumatology\/ker446","article-title":"PTPN22 R620W polymorphism in the ANCA-associated vasculitides","volume":"51","author":"Martorana","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2025102312473949900_GFU386C21","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/annrheumdis-2012-202803","article-title":"Genetics of toll like receptor 9 in ANCA associated vasculitides","volume":"73","author":"Husmann","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025102312473949900_GFU386C22","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.20072413","article-title":"Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake","volume":"205","author":"Willcocks","year":"2008","journal-title":"J Exp Med"},{"key":"2025102312473949900_GFU386C23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ng2046","article-title":"FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity","volume":"39","author":"Fanciulli","year":"2007","journal-title":"Nat Genet"},{"key":"2025102312473949900_GFU386C24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","article-title":"Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Nat Genet"},{"key":"2025102312473949900_GFU386C25","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2337\/db07-0029","article-title":"HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201\/DR4-DQB1*0302 DAISY population","volume":"56","author":"Baschal","year":"2007","journal-title":"Diabetes"},{"key":"2025102312473949900_GFU386C26","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.4049\/jimmunol.181.4.2869","article-title":"Delineating the role of the HLA-DR4 \u2018shared epitope\u2019 in susceptibility versus resistance to develop arthritis","volume":"181","author":"Taneja","year":"2008","journal-title":"J Immunol"},{"key":"2025102312473949900_GFU386C27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00439-004-1092-z","article-title":"New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes","volume":"114","author":"Jagiello","year":"2004","journal-title":"Hum Genet"},{"key":"2025102312473949900_GFU386C28","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/ard.2007.077693","article-title":"The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping","volume":"67","author":"Heckmann","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2025102312473949900_GFU386C29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/rheumatology\/kep057","article-title":"HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis","volume":"48","author":"Stassen","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2025102312473949900_GFU386C30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2010101058","article-title":"DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans","volume":"22","author":"Cao","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2025102312473949900_GFU386C31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.humimm.2011.02.017","article-title":"The association of HLA-DRB1 alleles with antineutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese patients","volume":"72","author":"Luo","year":"2011","journal-title":"Hum Immunol"},{"key":"2025102312473949900_GFU386C32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-122-8-199504150-00029","article-title":"HLA typing in patients with Wegener granulomatosis","volume":"122","author":"Cotch","year":"1995","journal-title":"Ann Intern Med"},{"key":"2025102312473949900_GFU386C33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/ard.51.2.246","article-title":"Association of Wegener's granulomatosis with HLA antigens and other genetic markers","volume":"51","author":"Papiha","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"2025102312473949900_GFU386C34","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/ki.1992.161","article-title":"HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens","volume":"41","author":"Spencer","year":"1992","journal-title":"Kidney Int"},{"key":"2025102312473949900_GFU386C35","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood.V94.7.2487.419k07_2487_2496","article-title":"Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules","volume":"94","author":"Witko-Sarsat","year":"1999","journal-title":"Blood"},{"key":"2025102312473949900_GFU386C36","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.4049\/jimmunol.165.6.3366","article-title":"Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition","volume":"165","author":"Campbell","year":"2000","journal-title":"J Immunol"},{"key":"2025102312473949900_GFU386C37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2249.2000.01228.x","article-title":"Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils","volume":"121","author":"Yang","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2025102312473949900_GFU386C38","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2025102312473949900_GFU386C39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","article-title":"Membrane expression of proteinase 3 is genetically determined","volume":"14","author":"Schreiber","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2025102312473949900_GFU386C40","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1046\/j.1523-1755.2000.00430.x","article-title":"Proteinase 3 gene polymorphisms and Wegener's granulomatosis","volume":"58","author":"Gencik","year":"2000","journal-title":"Kidney Int"},{"key":"2025102312473949900_GFU386C41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2796.1994.tb00842.x","article-title":"Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis","volume":"236","author":"Elzouki","year":"1994","journal-title":"J Intern Med"},{"key":"2025102312473949900_GFU386C42","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1365-2362.1996.2070553.x","article-title":"Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis","volume":"26","author":"Baslund","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"2025102312473949900_GFU386C43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/clim.2000.4962","article-title":"A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis","volume":"98","author":"Borgmann","year":"2001","journal-title":"Clin Immunol"},{"key":"2025102312473949900_GFU386C44","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0140-6736(05)66781-5","article-title":"Alpha1-antitrypsin deficiency","volume":"365","author":"Stoller","year":"2005","journal-title":"Lancet"},{"key":"2025102312473949900_GFU386C45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ki.1995.360","article-title":"The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis","volume":"48","author":"Segelmark","year":"1995","journal-title":"Kidney Int"},{"key":"2025102312473949900_GFU386C46","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.27742","article-title":"Alpha(1)-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis","volume":"62","author":"Mahr","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/ndt\/gft318","article-title":"Impact of rituximab trials on the treatment of ANCA-associated vasculitis","volume":"29","author":"Alberici","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312473949900_GFU386C48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"(4 Pt 2)","key":"2025102312473949900_GFU386C49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.lpm.2013.02.305","article-title":"L3. Are mononuclear cells predominant actors of endothelial damage in vasculitis?","volume":"42","author":"Abdulahad","year":"2013","journal-title":"Presse Med"},{"key":"2025102312473949900_GFU386C50","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.4049\/jimmunol.1200150","article-title":"PTPN22 alters the development of regulatory T cells in the thymus","volume":"188","author":"Maine","year":"2012","journal-title":"J Immunol"},{"key":"2025102312473949900_GFU386C51","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204796","article-title":"The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals","author":"Bayley","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025102312473949900_GFU386C52","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4049\/jimmunol.157.2.636","article-title":"CD28 costimulation prevents cell death during primary T cell activation","volume":"157","author":"Noel","year":"1996","journal-title":"J Immunol"},{"key":"2025102312473949900_GFU386C53","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/annrheumdis-2013-204164","article-title":"An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)","volume":"73","author":"Langford","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025102312473949900_GFU386C54","first-page":"950","article-title":"Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis","volume":"29","author":"Giscombe","year":"2002","journal-title":"J Rheumatol"},{"key":"2025102312473949900_GFU386C55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clim.2008.03.506","article-title":"Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis","volume":"128","author":"Slot","year":"2008","journal-title":"Clin Immunol"},{"key":"2025102312473949900_GFU386C56","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/rheumatology\/kep280","article-title":"CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis","volume":"48","author":"Kamesh","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2025102312473949900_GFU386C57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/CEJ.0000000000000059","article-title":"Relation of immune semaphorin\/plexin signaling to carcinogenesis","volume":"23","author":"Muzes","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"2025102312473949900_GFU386C58","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.38367","article-title":"The SEM6A6 locus is not associated with granulomatosis with polyangiitis or other forms of antineutrophil cytoplasmic antibody-associated vasculitides in Europeans: comment on the article by Xie et al","volume":"66","author":"Wieczorek","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025102312473949900_GFU386C59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s001090100263","article-title":"Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis","volume":"79","author":"Murakozy","year":"2001","journal-title":"J Mol Med (Berl)"},{"key":"2025102312473949900_GFU386C60","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1521-6616(03)00211-0","article-title":"Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis","volume":"109","author":"Bartfai","year":"2003","journal-title":"Clin Immunol"},{"key":"2025102312473949900_GFU386C61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1155\/S0962935193000018","article-title":"Biological significance of soluble IL-2 receptor","volume":"2","author":"Caruso","year":"1993","journal-title":"Mediators Inflamm"},{"key":"2025102312473949900_GFU386C62","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"2025102312473949900_GFU386C63","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI36022","article-title":"NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo","volume":"119","author":"Lakshmikanth","year":"2009","journal-title":"J Clin Invest"},{"key":"2025102312473949900_GFU386C64","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2025102312473949900_GFU386C65","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/1529-0131(199909)42:9<1823::AID-ANR5>3.0.CO;2-X","article-title":"Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse","volume":"42","author":"Dijstelbloem","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C66","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2249.1999.00960.x","article-title":"No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis","volume":"117","author":"Tse","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2025102312473949900_GFU386C67","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/hmg\/ddq216","article-title":"Copy number, linkage disequilibrium and disease association in the FCGR locus","volume":"19","author":"Niederer","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2025102312473949900_GFU386C68","doi-asserted-by":"crossref","first-page":"23382","DOI":"10.1074\/jbc.M101216200","article-title":"Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes","volume":"276","author":"Barnes","year":"2001","journal-title":"J Biol Chem"},{"key":"2025102312473949900_GFU386C69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/gene.2013.45","article-title":"Association of IRF5 polymorphism with MPO-ANCA-positive vasculitis in a Japanese population","volume":"14","author":"Kawasaki","year":"2013","journal-title":"Genes Immun"},{"key":"2025102312473949900_GFU386C70","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/rheumatology\/kem022","article-title":"Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis","volume":"46","author":"Popa","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2025102312473949900_GFU386C71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri1860","article-title":"Defensins in innate antiviral immunity","volume":"6","author":"Klotman","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2025102312473949900_GFU386C72","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/rheumatology\/ker419","article-title":"Higher DEFB4 genomic copy number in SLE and ANCA-associated small vasculitis","volume":"51","author":"Zhou","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2025102312473949900_GFU386C73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2249.1999.00889.x","article-title":"C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis","volume":"116","author":"Persson","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2025102312473949900_GFU386C74","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard.2007.081661","article-title":"Long-term follow-up of relapsing\/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H)","volume":"67","author":"Walsh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2025102312473949900_GFU386C75","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1046\/j.1523-1755.2000.00080.x","article-title":"Antiproteinase 3- and antimyeloperoxidase-associated vasculitis","volume":"57","author":"Franssen","year":"2000","journal-title":"Kidney Int"},{"key":"2025102312473949900_GFU386C76","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2215\/CJN.01020113","article-title":"Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis","volume":"8","author":"de Joode","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312473949900_GFU386C77","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ndt\/gfu084","article-title":"ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis","volume":"29","author":"Quintana","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312473949900_GFU386C78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2796.1998.00357.x","article-title":"Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies","volume":"244","author":"Franssen","year":"1998","journal-title":"J Intern Med"},{"key":"2025102312473949900_GFU386C79","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","article-title":"Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study","volume":"50","author":"Arulkumaran","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2025102312473949900_GFU386C80","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025102312473949900_GFU386C81","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/acr.20433","article-title":"A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis","volume":"63","author":"Suppiah","year":"2011","journal-title":"Arthritis Care Res"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/30\/suppl_1\/i37\/6838177\/gfu386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/30\/suppl_1\/i37\/6838177\/gfu386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:47:54Z","timestamp":1761238074000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/30\/suppl_1\/i37\/2324825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,18]]},"references-count":81,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2014,12,18]]},"published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfu386","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,4]]},"published":{"date-parts":[[2014,12,18]]}}}